SCENDIA PURCHASE AGREEMENT (Details Narrative) - USD ($) |
1 Months Ended | 12 Months Ended | ||
---|---|---|---|---|
Apr. 01, 2023 |
Aug. 31, 2023 |
Jul. 31, 2022 |
Dec. 31, 2022 |
|
Merger agreement cash consideration | $ 16,792,037 | |||
Cash consideration | $ 10,000,000.0 | |||
Number of shares | 486,145 | |||
Earnout payment | $ 693,000 | |||
Scendia Acquisition [Member] | ||||
Acquisition costs | $ 187,000 | |||
Purchase Agreement [Member] | ||||
Issuance of common stock for purchase of assets | 291,686 | |||
Number of shares issued | 94,798 | |||
Proceeds from offering | $ 1,950,000 | |||
Purchase Agreement [Member] | Scendia Biologics LLC [Member] | ||||
Merger agreement cash consideration | $ 1,600,000 | |||
Scendia Biologics LLC [Member] | ||||
Equity method ownership percentage | 50.00% | |||
Membership Interest Purchase Agreement [Member] | ||||
Equity method ownership percentage | 100.00% | |||
Scendia Biologics LLC [Member] | Scendia Purchase Agreement [Member] | ||||
Equity method ownership percentage | 100.00% |
X | ||||||||||
- Definition Earnout payment. No definition available.
|
X | ||||||||||
- Definition Amount of consideration transferred in asset acquisition. Includes, but is not limited to, cash, liability incurred by acquirer, and equity interest issued by acquirer. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
X | ||||||||||
- Definition This element represents acquisition-related costs incurred to effect a business combination which costs have been expensed during the period. Such costs include finder's fees; advisory, legal, accounting, valuation, and other professional or consulting fees; general administrative costs, including the costs of maintaining an internal acquisitions department; and may include costs of registering and issuing debt and equity securities. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Amount of asset recognized arising from contingent consideration in a business combination. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition The parent entity's interest in net assets of the subsidiary, expressed as a percentage. No definition available.
|
X | ||||||||||
- Definition The cash inflow from the additional capital contribution to the entity. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition The number of shares issued or sold by the subsidiary or equity method investee per stock transaction. No definition available.
|
X | ||||||||||
- Definition Number of shares of stock issued as of the balance sheet date, including shares that had been issued and were previously outstanding but which are now held in the treasury. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Number of shares of stock issued during the period as part of a transaction to acquire assets that do not qualify as a business combination. No definition available.
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|